Skip to content
2000
Volume 5, Issue 9
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Chemokines belong to a large family of chemoattractant molecules involved in the directed migration of immune cells. They achieve their cellular effects by direct interaction with cell surface receptors. The chemokine receptor CCR1 appears to be involved in a variety of proinflammatory and autoimmune diseases and this makes it a very attractive therapeutic target. This review discusses the identification, chemistry, biology and therapeutic potential of BX 471 a potent CCR1 antagonist that is currently in the clinic for a variety of indications.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/1389557054867057
2005-09-01
2025-09-03
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/1389557054867057
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test